114 related articles for article (PubMed ID: 12557256)
1. Downregulation of hepatitis B surface antigen expression in human hepatocellular carcinoma cell lines by HD-03, a polyherbal formulation.
Yeh SF; Gupta M; Sarma DN; Mitra SK
Phytother Res; 2003 Jan; 17(1):89-91. PubMed ID: 12557256
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus.
Jayaram S; Thyagarajan SP
Indian J Pathol Microbiol; 1996 Jul; 39(3):211-5. PubMed ID: 8972151
[TBL] [Abstract][Full Text] [Related]
3. Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Gerber MA; Garfinkel E; Hirschman SZ; Thung SN; Panagiotatos T
J Immunol; 1981 Mar; 126(3):1085-9. PubMed ID: 6161957
[TBL] [Abstract][Full Text] [Related]
4. Effect of human leukocyte interferon on HBsAg production in PLC/PRF/5 human hepatoma cell line.
Hajnická V; Stancek D
Acta Virol; 1987 Sep; 31(5):404-9. PubMed ID: 2891279
[TBL] [Abstract][Full Text] [Related]
5. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines.
Ho CK; Huang YL; Chen CC
Planta Med; 2002 Nov; 68(11):975-9. PubMed ID: 12451486
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
Aoki N; Thung SN; Gerber MA
Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
[TBL] [Abstract][Full Text] [Related]
7. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.
Chiang LC; Ng LT; Liu LT; Shieh DE; Lin CC
Planta Med; 2003 Aug; 69(8):705-9. PubMed ID: 14531019
[TBL] [Abstract][Full Text] [Related]
10. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
11. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P
Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-hepatoma activity of fifteen natural medicines from Canada.
Lin LT; Liu LT; Chiang LC; Lin CC
Phytother Res; 2002 Aug; 16(5):440-4. PubMed ID: 12203264
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the antiviral activity of medicinal plants against the hepatitis B virus (HBV) in PLC/PRF/5 cells].
González González RL; Roque Quintero A; Morier Díaz L; Rodríguez Lay Lde L
Rev Cubana Med Trop; 2006; 58(2):103-8. PubMed ID: 23427427
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity of some medicinal plants from Georgian Amaryllidaceae.
Jokhadze M; Eristavi L; Kutchukhidze J; Chariot A; Angenot L; Tits M; Jansen O; Frédérich M
Phytother Res; 2007 Jul; 21(7):622-4. PubMed ID: 17357974
[TBL] [Abstract][Full Text] [Related]
17. [The effects of extracts from Arenaria kansuensis on the levels of HBsAG and HBeAg in HepG2.2.15 cells].
Tang QN; Feng M; Gong SJ; Dai ZK; Zhou YZ; Xv Q
Zhong Yao Cai; 2008 Aug; 31(8):1212-6. PubMed ID: 19112905
[TBL] [Abstract][Full Text] [Related]
18. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
[TBL] [Abstract][Full Text] [Related]
19. [Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line].
Ji XH; Qin YZ; Wang WY; Zhu JY; Liu XT
Zhongguo Zhong Yao Za Zhi; 1993 Aug; 18(8):496-8, 511. PubMed ID: 8011099
[TBL] [Abstract][Full Text] [Related]
20. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
